Siemens Healthineers · 5 hours ago
Strategy Intern
Siemens Healthineers is a leader in medical technology, dedicated to pioneering breakthroughs in healthcare. They are seeking a Strategy Intern to support the Strategy Team by updating market analysis and identifying growth opportunities in the radiopharmaceutical therapies market, particularly in China.
Health CareHealth DiagnosticsMedicalMedical Device
Responsibilities
Updating a market analysis of the global radiopharmaceutical therapies market, especially in China
Helping identify opportunities for growth and build potential strategies in the global radiopharmaceutical therapies market with a focus on China
Supporting in the preparation and analysis of strategic topics, as needed
Qualification
Required
Currently enrolled in and pursuing studies at a foreign degree- or certificate-granting post-secondary academic institution outside the United States OR Has graduated from such an institution no more than 12 months prior to his or her exchange visitor program start date
Minimum 3.0 GPA
Preferred
Knowledge of the Chinese healthcare market
Benefits
Medical insurance
Dental insurance
Vision insurance
401(k) retirement plan
Life insurance
Long-term and short-term disability insurance
Paid parking/public transportation
Paid time off
Paid sick and safe time
Company
Siemens Healthineers
Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services. It is a sub-organization of Siemens.
H1B Sponsorship
Siemens Healthineers has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (104)
2024 (70)
2023 (64)
2022 (89)
2021 (50)
2020 (86)
Funding
Current Stage
Public CompanyTotal Funding
$2.76BKey Investors
Ontario Together Fund
2021-05-25Grant· $2.5M
2021-03-25Post Ipo Equity· $2.76B
2018-03-16IPO
Leadership Team
Recent News
2026-01-16
Company data provided by crunchbase